P38γ modulates the lipid metabolism in non‐alcoholic fatty liver disease by regulating the <scp>JAK–STAT</scp> signaling pathway-Reference-Cited by-同舟云学术

P38γ modulates the lipid metabolism in non‐alcoholic fatty liver disease by regulating the JAK–STAT signaling pathway

Published:2022-12-17 Issue:1 Volume:37 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Yao Yan¹²,Luo Zhi‐pan¹³,Li Hai‐wen⁴⁵,Wang Shu‐xian¹²,Wu Yin‐cui¹²,Hu Ying¹²,Hu Shuang¹²,Yang Chen‐chen¹²,Yang Jun‐fa¹²,Wang Jian‐peng⁶,Peng Li¹²,Chen Fei¹²,Pan Lin‐xin⁷,Xu Tao¹²^ORCID

Affiliation:

1. Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University Hefei China

2. Institute for Liver Diseases of Anhui Medical University Hefei China

3. The First Affiliated Hospital of Anhui Medical University Hefei China

4. Department of Gastroenterology The Third Affiliated Hospital of Anhui Medical University Hefei China

5. Department of Gastroenterology The First Affiliated Hospital of Zhengzhou University Zhengzhou China

6. First Clinical Medical College Anhui Medical University Hefei China

7. School of Life Sciences Anhui Medical University Hefei China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202200939RR